RxDoctor Payments DataLook up a doctor →

Makena Turner, PA

Physician Assistant · Spokane, WANPI 1093306169

Payments from drug & device makers

$19,705in general payments, 2019–2025

Across 916 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Novartis$1K
  • Pfizer$1K
  • E.r. Squibb & Sons, L.L.C.$985
  • Bristol Myers Squibb$873
  • AstraZeneca$741
  • plus $13K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)82$1,644
Novartis72$1,274
Pfizer66$1,006
E.r. Squibb & Sons, L.L.C.62$985
Bristol Myers Squibb48$873
AstraZeneca(2 entities)32$741
Incyte Corporation33$731
AbbVie25$708
Merck30$704
Seagen Inc.21$641
Astellas Pharma US Inc22$607
Genentech USA, Inc.32$585
Amgen23$523
Lilly USA, LLC19$492
Pharmacyclics LLC, An Abbvie Company20$487
Takeda Pharmaceuticals U.S.A., Inc.16$460
Sanofi18$392
Regeneron Healthcare Solutions, Inc.12$358
Myriad Genetic Laboratories, Inc.25$353
Eisai Inc.17$351
EMD Serono, Inc.11$349
Blueprint Medicines Corporation14$303
Sobi, Inc8$300
Exelixis Inc.12$276
Boehringer Ingelheim11$274
GSK14$267
Tersera Therapeutics LLC9$255
Array Biopharma Inc11$203
Alnylam Pharmaceuticals Inc.9$195
Acrotech Biopharma Inc.9$193
Beigene USA, Inc.7$181
Jazz Pharmaceuticals Inc.8$168
Bayer8$158
Epizyme, Inc.4$147
Gilead(2 entities)6$139
Taiho Oncology, Inc.4$109
Janssen Scientific Affairs, LLC1$106
Immunocore Limited3$98
AVEO Pharmaceuticals, Inc.5$96
Puma Biotechnology, Inc.5$96
Springworks Therapeutics, Inc.4$95
Sanofi-aventis U.S. LLC2$93
Agios Pharmaceuticals, Inc.4$90
Foundation Medicine, Inc.5$85
Stemline Therapeutics Inc.3$85
Deciphera Pharmaceuticals Inc.3$81
Beone Medicines USA, Inc.3$80
Daiichi Sankyo Inc.3$76
Servier Pharmaceuticals LLC4$76
Iovance Biotherapeutics, Inc.2$76
Sun Pharmaceutical Industries Inc.3$71
Acceleron Pharma, Inc.3$65
Spectrum Pharmaceuticals Inc.3$61
Morphosys, US Inc.3$58
Pharmacosmos Therapeutics Inc.3$58
Rigel Pharmaceuticals, Inc.2$54
Fresenius Kabi USA, LLC3$53
CTI Biopharma Corp.2$53
Azurity Pharmaceuticals, Inc.2$45
G1 Therapeutics, Inc.2$44

How this compares

$19,705 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington →

Medicare billing

Part B allowed, 2024
$75,148
Medicare patients
44
Services billed
2,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Spokane

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →